Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_001130173.2(MYB):c.1064C>T(p.Pro355Leu) variant causes a missense change. The variant allele was found at a frequency of 0.000013 in 1,614,052 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
MYB (HGNC:7545): (MYB proto-oncogene, transcription factor) This gene encodes a protein with three HTH DNA-binding domains that functions as a transcription regulator. This protein plays an essential role in the regulation of hematopoiesis. This gene may be aberrently expressed or rearranged or undergo translocation in leukemias and lymphomas, and is considered to be an oncogene. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]
Review Status: criteria provided, single submitter
Collection Method: clinical testing
The c.1064C>T (p.P355L) alteration is located in exon 9 (coding exon 9) of the MYB gene. This alteration results from a C to T substitution at nucleotide position 1064, causing the proline (P) at amino acid position 355 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Loss of glycosylation at P355 (P = 0.0587);Loss of glycosylation at P355 (P = 0.0587);Loss of glycosylation at P355 (P = 0.0587);Loss of glycosylation at P355 (P = 0.0587);.;Loss of glycosylation at P355 (P = 0.0587);Loss of glycosylation at P355 (P = 0.0587);.;Loss of glycosylation at P355 (P = 0.0587);Loss of glycosylation at P355 (P = 0.0587);.;